“…Nowadays, research in the field of antimicrobial drug design is focused on the discovery of novel targets and chemical entities that possess antibacterial activity in order to Compounds bearing two thiazole rings, such as the antitumor drug bleomycin, the antiretroviral agent ritonavir, the pharmacokinetic enhancer for HIV drugs cobicistat, and the antibacterial agent cefditoren, have been authorized on the pharmaceutical market (Figure 2) [2,5]. The high medicinal significance of this scaffold has attracted considerable attention from many researchers and encouraged the design and synthesis of numerous thiazoleand bisthiazole-containing compounds with diverse pharmacological activities, such as antibacterial [6], antifungal [7], antiprotozoal [8], antiviral [9,10], anticancer [11], antiinflammatory [12][13][14][15][16], antioxidant [17], analgesic [18], anticonvulsant [19], antidiabetic [20], and antihypertensive [21] activities. Furthermore, thiazole compounds exhibiting a promising biological potential for the treatment of Alzheimer's disease [22,23] and metabolic syndrome [24] have been reported in the scientific literature.…”